Venrock Partners, L.P.

10% owner at Trubion Pharmaceuticals, Inc · on record since Oct 25, 2006
10% owner at ALIMERA SCIENCES INC · on record since Apr 28, 2010
10% owner at Anacor Pharmaceuticals, Inc. · on record since Nov 23, 2010
10% owner at ON Semiconductor Connectivity Solutions, Inc. · on record since Oct 27, 2016
10% owner at ACCELERON PHARMA INC · on record since Sep 25, 2013
10% owner at Achaogen, Inc. · on record since Mar 17, 2014
10% owner at Bellerophon Therapeutics, Inc. · on record since Sep 17, 2018

Insider trading activity of Venrock Partners, L.P.

Transactions on record: 13; since Apr 28, 2010

Open-market buys: 7; $4M

Open-market sells: 0

Companies traded: 2; last filing Sep 17, 2018

Figures computed from official regulatory filings — .

Companies where Venrock Partners, L.P. has traded

Bellerophon Therapeutics, Inc.6 tx · $596.4K · Sep 17, 2018
ALIMERA SCIENCES INC7 tx · $3.4M · Apr 28, 2010

Track record of Venrock Partners, L.P.

Open-market buys: 7

Last buy: Sep 17, 2018

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of Venrock Partners, L.P.

Co-insiders of Venrock Partners, L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	75,000	1.19 USD	$89.3K	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	75,000	1.23 USD	$92.3K	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	60,000	1.18 USD	$70.8K	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Aug 16, 2018	Buy	272,000	0.65 USD	$176.8K	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Aug 16, 2018	Buy	190,977	0.65 USD	$124.1K	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Aug 16, 2018	Buy	66,393	0.65 USD	$43.2K	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	Other	2,243,732	—	—	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	Other	465,157	—	—	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	OtherD (derivative)	-2,243,732	0.00	—	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	Other	934,110	—	—	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	OtherD (derivative)	-934,110	0.00	—	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	Buy	306,071	11.00	$3.4M	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	OtherD (derivative)	-465,157	0.00	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	75,000	1.19 USD	$89.3K	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	75,000	1.23 USD	$92.3K	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 17, 2018	Buy	60,000	1.18 USD	$70.8K	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Aug 16, 2018	Buy	272,000	0.65 USD	$176.8K	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Aug 16, 2018	Buy	190,977	0.65 USD	$124.1K	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Aug 16, 2018	Buy	66,393	0.65 USD	$43.2K	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	Other	2,243,732	—	—	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	Other	465,157	—	—	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	OtherD (derivative)	-2,243,732	0.00	—	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	Other	934,110	—	—	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	OtherD (derivative)	-934,110	0.00	—	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	Buy	306,071	11.00	$3.4M	SEC
ALIMERA SCIENCES INCListing unverified	Apr 28, 2010	OtherD (derivative)	-465,157	0.00	—	SEC